Nifty
:
24323.85
Sensex
:
79996.60
21.70 (0.09%)
-53.07 (-0.07%)
Nifty
Sensex
:
:
24323.85
79996.60
21.70 (0.09%)
-53.07 (-0.07%)

Ind-Swift Laboratories Ltd.

Pharmaceuticals & Drugs

Rating :
46/99

BSE: 532305 | NSE: INDSWFTLAB

NSE BSE
133.33
05-Jul-2024
  • Open
  • High
  • Low
  • Previous Close
  •  127.50
  •  134.99
  •  127.37
  •  127.15
  • Volume
  • Traded Value (lacs)
  • 52 Week High
  • 52 Week Low
  •  969740
  •  1281.51
  •  139.00
  •  81.85

Stock Summary

  • Market Cap(Crs)
  • Stock P:E
  • Face Value
  • 785.56
  • 1.87
  • 10
  • Enterprise Value(Crs)
  • Dividend Yield
  • Price:Book Value
  • 370.25
  • N/A
  • 0.84

Shareholding Pattern

  • Promoter
  • Corporate
  • Public
  • 42.00%
  • 16.86%
  • 30.46%
  • FII
  • DII
  • Others
  • 0.26%
  • 0.00%
  • 10.42%

Chart

Price | P:E | P:BV | EV:EBITDA | MCap:Sales | EPS

Revenue CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 2.26
  • 9.80
  • 10.64

EBITDA CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • 14.55
  • 12.69
  • 4.63

PAT CAGR (%)

  • 10 Years
  • 5 Years
  • 3 Years
  • -
  • 10.56
  • -

P:E (Median)

  • 8 Years
  • 5 Years
  • 3 Years
  • 3.68
  • 8.60
  • 11.49

P:BV (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 0.86
  • 0.84
  • 0.96

EV:EBITDA (Average)

  • 8 Years
  • 5 Years
  • 3 Years
  • 8.21
  • 6.28
  • 5.47

Quarterly Results

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 24
Mar 23
Var%
Dec 23
Dec 22
Var%
Sep 23
Sep 22
Var%
Jun 23
Jun 22
Var%
Net Sales
393.33
304.25
29.28%
287.51
312.69
-8.05%
289.71
310.21
-6.61%
310.34
280.17
10.77%
Expenses
430.64
240.57
79.01%
235.82
258.92
-8.92%
224.02
251.46
-10.91%
250.04
227.16
10.07%
EBITDA
-37.30
63.67
-
51.69
53.76
-3.85%
65.70
58.75
11.83%
60.30
53.00
13.77%
EBIDTM
-9.48%
20.93%
17.98%
17.19%
22.68%
18.94%
19.43%
18.92%
Other Income
25.25
10.21
147.31%
7.11
8.36
-14.95%
7.40
7.54
-1.86%
5.61
7.39
-24.09%
Interest
-11.47
21.82
-
21.05
22.38
-5.94%
21.14
23.98
-11.84%
20.38
23.98
-15.01%
Depreciation
12.67
9.29
36.38%
13.56
15.39
-11.89%
13.19
16.41
-19.62%
13.88
16.28
-14.74%
PBT
373.34
16.13
2,214.57%
24.19
24.35
-0.66%
38.77
25.91
49.63%
31.64
20.14
57.10%
Tax
134.47
41.17
226.62%
4.67
-3.27
-
6.93
0.56
1,137.50%
14.24
0.22
6,372.73%
PAT
238.87
-25.05
-
19.53
27.62
-29.29%
31.83
25.34
25.61%
17.40
19.92
-12.65%
PATM
60.73%
-8.23%
6.79%
8.83%
10.99%
8.17%
5.61%
7.11%
EPS
40.42
-4.25
-
3.29
4.65
-29.25%
5.36
4.29
24.94%
2.92
3.36
-13.10%

Annual Results

Consolidated Figures in Rs. Crores /

Standalone
Description
TTM
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Net Sales
1,280.89
1,207.31
1,038.73
891.34
779.64
756.60
762.52
697.42
653.25
660.45
965.08
Net Sales Growth
6.09%
16.23%
16.54%
14.33%
3.05%
-0.78%
9.33%
6.76%
-1.09%
-31.57%
 
Cost Of Goods Sold
734.87
655.59
537.43
451.44
396.66
403.36
390.56
392.19
353.01
407.39
754.92
Gross Profit
546.02
551.73
501.30
439.90
382.98
353.24
371.96
305.24
300.23
253.07
210.16
GP Margin
42.63%
45.70%
48.26%
49.35%
49.12%
46.69%
48.78%
43.77%
45.96%
38.32%
21.78%
Total Expenditure
1,140.52
978.11
843.11
708.54
636.16
630.48
628.43
591.47
545.97
571.69
906.18
Power & Fuel Cost
-
76.07
58.45
37.31
34.65
37.44
29.58
26.00
22.65
34.78
36.82
% Of Sales
-
6.30%
5.63%
4.19%
4.44%
4.95%
3.88%
3.73%
3.47%
5.27%
3.82%
Employee Cost
-
126.17
117.40
97.86
95.92
90.98
88.12
69.65
62.76
50.65
44.95
% Of Sales
-
10.45%
11.30%
10.98%
12.30%
12.02%
11.56%
9.99%
9.61%
7.67%
4.66%
Manufacturing Exp.
-
43.41
40.85
64.24
59.30
50.06
63.50
43.40
38.56
30.13
26.35
% Of Sales
-
3.60%
3.93%
7.21%
7.61%
6.62%
8.33%
6.22%
5.90%
4.56%
2.73%
General & Admin Exp.
-
38.17
36.03
27.17
27.58
27.27
28.69
23.33
21.54
20.33
22.37
% Of Sales
-
3.16%
3.47%
3.05%
3.54%
3.60%
3.76%
3.35%
3.30%
3.08%
2.32%
Selling & Distn. Exp.
-
37.29
39.03
28.74
21.65
21.30
27.92
29.06
28.87
28.33
13.95
% Of Sales
-
3.09%
3.76%
3.22%
2.78%
2.82%
3.66%
4.17%
4.42%
4.29%
1.45%
Miscellaneous Exp.
-
1.42
13.93
1.77
0.40
0.07
0.06
7.86
18.57
0.09
13.95
% Of Sales
-
0.12%
1.34%
0.20%
0.05%
0.01%
0.01%
1.13%
2.84%
0.01%
0.71%
EBITDA
140.39
229.20
195.62
182.80
143.48
126.12
134.09
105.95
107.28
88.76
58.90
EBITDA Margin
10.96%
18.98%
18.83%
20.51%
18.40%
16.67%
17.59%
15.19%
16.42%
13.44%
6.10%
Other Income
45.37
33.50
43.50
22.71
33.46
36.91
25.82
22.62
15.91
22.25
14.17
Interest
51.10
92.17
95.55
100.22
106.65
92.24
35.38
90.27
106.42
117.29
116.66
Depreciation
53.30
57.36
131.04
87.29
90.06
104.05
86.62
88.26
84.75
84.29
65.77
PBT
467.94
113.17
12.53
18.01
-19.77
-33.26
37.92
-49.96
-67.98
-90.56
-109.35
Tax
160.31
38.69
14.68
21.16
1.42
20.73
14.01
-16.17
-24.09
-23.98
-20.05
Tax Rate
34.26%
44.72%
117.16%
117.49%
-7.18%
41.73%
38.94%
29.24%
29.10%
16.73%
14.11%
PAT
307.63
47.83
-2.15
-3.15
-21.19
28.95
21.98
-39.13
-58.69
-119.37
-122.01
PAT before Minority Interest
307.63
47.83
-2.15
-3.15
-21.19
28.95
21.98
-39.13
-58.69
-119.37
-122.01
Minority Interest
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
PAT Margin
24.02%
3.96%
-0.21%
-0.35%
-2.72%
3.83%
2.88%
-5.61%
-8.98%
-18.07%
-12.64%
PAT Growth
543.17%
-
-
-
-
31.71%
-
-
-
-
 
EPS
52.05
8.09
-0.36
-0.53
-3.59
4.90
3.72
-6.62
-9.93
-20.20
-20.64

Results Balance Sheet

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Shareholder's Funds
681.93
600.97
603.51
640.64
587.81
553.24
531.32
517.43
594.85
725.23
Share Capital
59.81
59.81
59.81
59.81
48.29
46.00
45.46
41.68
41.68
40.96
Total Reserves
622.12
541.17
543.70
580.83
539.53
505.69
483.39
475.74
553.17
674.95
Non-Current Liabilities
741.18
813.57
840.15
828.33
901.32
437.80
494.76
717.24
811.33
983.36
Secured Loans
752.60
847.78
884.13
885.96
953.86
503.97
563.69
666.84
723.03
862.23
Unsecured Loans
0.00
0.00
0.00
4.93
11.72
16.52
28.32
79.48
93.11
102.17
Long Term Provisions
17.79
17.03
15.73
14.76
14.34
13.32
9.16
0.00
0.00
0.00
Current Liabilities
371.09
334.47
314.52
323.07
356.00
935.93
1,005.02
950.81
832.82
630.01
Trade Payables
203.99
175.95
138.82
135.23
126.68
128.64
102.36
132.43
134.11
213.71
Other Current Liabilities
105.67
89.10
81.29
72.92
136.49
490.25
496.93
314.60
248.67
21.50
Short Term Borrowings
49.17
64.03
93.43
114.93
92.52
311.31
405.70
503.66
450.05
390.97
Short Term Provisions
12.25
5.39
0.98
0.00
0.31
5.73
0.03
0.12
0.00
3.83
Total Liabilities
1,794.20
1,748.90
1,758.09
1,792.04
1,845.13
1,926.97
2,031.10
2,185.48
2,239.00
2,338.60
Net Block
585.04
627.53
738.65
843.14
901.20
924.59
1,032.56
1,098.73
1,116.82
1,173.77
Gross Block
1,330.92
1,316.68
1,302.04
1,359.32
1,378.95
1,349.27
1,406.84
1,420.51
1,404.21
1,405.28
Accumulated Depreciation
745.88
689.15
563.38
516.18
477.75
424.68
374.28
321.78
287.40
231.51
Non Current Assets
629.68
673.56
813.91
929.00
1,009.05
1,087.71
1,202.46
1,263.78
1,319.18
1,349.72
Capital Work in Progress
7.71
10.31
18.84
11.45
19.87
68.60
70.26
78.47
112.83
78.10
Non Current Investment
30.34
29.06
35.53
17.45
31.03
31.02
31.09
17.63
17.52
17.07
Long Term Loans & Adv.
4.17
3.96
6.11
56.95
56.95
63.50
54.24
68.96
72.00
80.78
Other Non Current Assets
0.00
0.00
0.00
0.00
0.00
0.00
14.31
0.00
0.00
0.00
Current Assets
1,163.12
1,073.32
941.88
863.03
836.09
839.26
828.64
921.70
919.82
988.89
Current Investments
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Inventories
438.60
428.50
375.67
342.82
316.61
316.91
343.56
356.02
348.31
377.03
Sundry Debtors
505.32
454.78
432.39
396.45
350.85
407.76
357.27
372.45
389.04
443.85
Cash & Bank
18.20
21.48
11.60
10.58
29.97
9.45
16.13
22.58
19.84
20.59
Other Current Assets
201.00
16.92
56.33
38.73
138.66
105.14
111.69
170.66
162.64
147.41
Short Term Loans & Adv.
191.98
151.64
65.90
74.45
96.84
92.09
95.37
157.41
144.03
126.33
Net Current Assets
792.03
738.86
627.36
539.96
480.08
-96.67
-176.37
-29.11
87.01
358.87
Total Assets
1,792.80
1,746.88
1,755.79
1,792.03
1,845.14
1,926.97
2,031.10
2,185.48
2,239.00
2,338.61

Cash Flow

Consolidated Figures in Rs. Crores /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Cash From Operating Activity
194.62
150.27
134.95
125.24
-64.40
73.09
95.57
79.43
98.40
65.53
PBT
113.17
12.53
18.01
-19.77
-33.26
37.87
-49.96
-67.98
-90.57
-109.35
Adjustment
132.78
225.66
179.35
176.02
186.26
103.64
167.95
186.30
169.93
144.59
Changes in Working Capital
-51.33
-87.92
-62.41
-31.01
-214.80
-68.41
-22.42
-38.89
22.87
39.54
Cash after chg. in Working capital
194.62
150.27
134.95
125.24
-61.80
73.09
95.57
79.43
102.23
74.78
Interest Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Tax Paid
0.00
0.00
0.00
0.00
-2.60
0.00
0.00
0.00
-3.83
-9.25
Other Direct Exp. Paid
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Extra & Other Items
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
0.00
Cash From Investing Activity
-13.37
4.77
-10.17
-9.10
-12.47
-17.40
-30.94
-29.56
-35.61
-27.39
Net Fixed Assets
-12.34
-8.59
50.42
31.26
19.05
59.23
21.87
18.07
-34.69
29.24
Net Investments
25.56
-55.35
-28.97
12.52
0.24
0.23
-12.97
-0.05
0.88
0.06
Others
-26.59
68.71
-31.62
-52.88
-31.76
-76.86
-39.84
-47.58
-1.80
-56.69
Cash from Financing Activity
-185.66
-140.88
-123.75
-133.26
99.62
-61.98
-68.90
-47.92
-63.72
-37.76
Net Cash Inflow / Outflow
-4.41
14.17
1.03
-17.12
22.76
-6.30
-4.27
1.94
-0.94
0.38
Opening Cash & Equivalents
21.48
11.60
10.58
29.97
9.45
16.13
22.58
19.84
20.59
18.28
Closing Cash & Equivalent
17.07
25.77
11.61
10.58
29.97
9.45
16.13
21.78
19.84
20.59

Financial Ratios

Consolidated /

Standalone
Description
Mar 23
Mar 22
Mar 21
Mar 20
Mar 19
Mar 18
Mar 17
Mar 16
Mar 15
Mar 14
Book Value (Rs.)
84.25
68.33
66.35
70.21
73.01
65.58
58.08
56.78
67.21
93.07
ROA
2.70%
-0.12%
-0.18%
-1.17%
1.53%
1.11%
-1.86%
-2.65%
-5.22%
-5.18%
ROE
10.61%
-0.54%
-0.78%
-5.56%
8.99%
7.89%
-15.89%
-23.11%
-36.36%
-27.88%
ROCE
13.25%
7.88%
8.31%
5.97%
9.25%
4.59%
2.19%
1.40%
-1.52%
-1.46%
Fixed Asset Turnover
0.92
0.80
0.67
0.57
0.56
0.56
0.51
0.48
0.48
0.71
Receivable days
144.51
154.46
168.41
174.12
182.19
181.25
185.94
206.44
223.20
158.98
Inventory Days
130.51
140.01
145.99
153.65
152.15
156.48
178.26
190.95
194.38
153.77
Payable days
105.77
106.89
110.78
68.85
63.73
60.79
64.19
12.73
29.95
80.99
Cash Conversion Cycle
169.25
187.58
203.62
258.91
270.60
276.94
300.00
384.67
387.63
231.76
Total Debt/Equity
1.71
2.33
2.56
2.48
3.21
4.38
4.77
6.25
5.12
3.56
Interest Cover
1.94
1.13
1.18
0.81
1.54
2.02
0.39
0.22
-0.22
-0.22

Annual Reports:

FY 2023
FY 2022
FY 2021
FY 2020
FY 2019
FY 2018
FY 2017
FY 2016
FY 2015
FY 2014

News Update:


  • Ind-Swift Laboratories incorporates wholly owned subsidiary in UAE
    20th May 2024, 12:12 PM

    The certificate of incorporation has been received on May 17, 2024 from the Registrar of Companies of the Meydan - Free Zone

    Read More
  • Ind-Swift Lab. - Quarterly Results
    13th May 2024, 19:47 PM

    Read More
  • Ind-Swift Laboratories to incorporate wholly owned subsidiary in UAE
    19th Apr 2024, 12:15 PM

    The WOS intends to strategically invest in pharmaceutical and allied activities

    Read More

Source: www.accordfintech.com | DISCLAIMER: Information is provided " as is" and solely for informational purposes, not for trading purposes or advice, and may be delayed.